Does regional citrate and calcium anticoagulation prolong continuous renal replacement therapy circuit life compared to regional heparin and protamine anticoagulation in critically ill adults?
Regional citrate anticoagulation prolongs CRRT circuit life and reduces adverse events compared to regional heparin in critically ill adults.
Regional citrate and calcium anticoagulation prolongs continuous renal replacement therapy circuit life compared with regional heparin and protamine anticoagulation, does not affect cytokine levels, and is associated with fewer adverse events.
Gattas et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: